This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kalfa, V. C.
Right arrow Articles by Brogden, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kalfa, V. C.
Right arrow Articles by Brogden, K. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2001, p. 3256-3261, Vol. 45, No. 11
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.11.3256-3261.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Congeners of SMAP29 Kill Ovine Pathogens and Induce Ultrastructural Damage in Bacterial Cells

V. C. Kalfa,1 H. P. Jia,2 R. A. Kunkle,1 P. B. McCray Jr.,2 B. F. Tack,3 and K. A. Brogden1,*

Respiratory Diseases of Livestock Research Unit, USDA Agricultural Research Service, National Animal Disease Center, Ames, Iowa 50010,1 and Departments of Pediatrics2 and Microbiology,3 College of Medicine, The University of Iowa, Iowa City, Iowa 52242

Received 19 January 2001/Returned for modification 5 June 2001/Accepted 8 August 2001

SMAP29, an ovine cathelicidin, was systematically altered to create a family of 23 related peptides for MIC and minimum bactericidal concentration determinations. SMAP28, SMAP29, and a derivative of SMAP29 called ovispirin were all antimicrobial. However, many congeners of SMAP29 and ovispirin were not as active as the parent molecules. With immunoelectron microscopy, SMAP29 was seen on membranes and within the cytoplasm of Pseudomonas aeruginosa PAO1.


* Corresponding author. Mailing address: Respiratory Diseases of Livestock Research Unit, National Animal Disease Center, 2300 Dayton Ave., P.O. Box 70, Ames, IA 50010. Phone: (515) 663-7534. Fax: (515) 663-8458. E-mail: kbrogden{at}nadc.ars.usda.gov.


Antimicrobial Agents and Chemotherapy, November 2001, p. 3256-3261, Vol. 45, No. 11
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.11.3256-3261.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lisanby, M. W., Swiecki, M. K., Dizon, B. L. P., Pflughoeft, K. J., Koehler, T. M., Kearney, J. F. (2008). Cathelicidin Administration Protects Mice from Bacillus anthracis Spore Challenge. J. Immunol. 181: 4989-5000 [Abstract] [Full Text]  
  • Song, Z., Wu, H., Mygind, P., Raventos, D., Sonksen, C., Kristensen, H.-H., Hoiby, N. (2005). Effects of Intratracheal Administration of Novispirin G10 on a Rat Model of Mucoid Pseudomonas aeruginosa Lung Infection. Antimicrob. Agents Chemother. 49: 3868-3874 [Abstract] [Full Text]  
  • Sawai, M. V., Waring, A. J., Kearney, W. R., McCray, P. B. Jr, Forsyth, W. R., Lehrer, R. I., Tack, B. F. (2002). Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng Des Sel 15: 225-232 [Abstract] [Full Text]